Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingfeng Chen

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Journal of Medicinal Chemistry|May 9, 2024
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory DiseasesLingfeng Chen, Ruixiang Luo, Lin Ma, et al.
Nature Chemical Biology|January 22, 2020
Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylationLingfeng Chen, William M Marsiglia, Huaibin Chen, et al.
European Journal of Medicinal Chemistry|April 6, 2023
Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatmentRuixiang Luo, Weitao Fu, Jingjing Shao, et al.
Journal of Medicinal Chemistry|December 7, 2024
Discovery of Novel MyD88 Inhibitor A5S to Alleviate Acute Lung Injury with Favorable Drug-like PropertiesPan Chen, Yu Zou, Xiemin Wang, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Journal of Medicinal Chemistry|May 9, 2024
Discovery of LC-MI-3: A Potent and Orally Bioavailable Degrader of Interleukin-1 Receptor-Associated Kinase 4 for the Treatment of Inflammatory DiseasesLingfeng Chen, Ruixiang Luo, Lin Ma, et al.
Nature Chemical Biology|January 22, 2020
Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylationLingfeng Chen, William M Marsiglia, Huaibin Chen, et al.
European Journal of Medicinal Chemistry|April 6, 2023
Discovery of a potent and selective allosteric inhibitor targeting the SHP2 tunnel site for RTK-driven cancer treatmentRuixiang Luo, Weitao Fu, Jingjing Shao, et al.
Journal of Medicinal Chemistry|December 7, 2024
Discovery of Novel MyD88 Inhibitor A5S to Alleviate Acute Lung Injury with Favorable Drug-like PropertiesPan Chen, Yu Zou, Xiemin Wang, et al.
Pageof 13